Trade-Ideas: Thursday, Monday, August 12th, 2019Trade ideas for next week:1) BDSI $4.36* Continuation swing opportunity.* Gained 16% last week.* Released strong earnings last week with strong revenue … [Read more...] about Trade-Ideas for Monday, August 12th, 2019
Biopharma Stock Watch July 29th-August 2nd
Source: MS Money Moves Stocks closed higher last week in anticipation of the Fed to cut interest rates for the first time since the 2008 financial crisis. While this is welcomed by investors we … [Read more...] about Biopharma Stock Watch July 29th-August 2nd
Trevena Inc: A Budding Innovator Rooted In A Nobel Prize Winning Discovery
On Wednesday June 12th, 2019 the MS Money Moves executive team spoke over the phone with Trevena Inc. (Nasdaq: TRVN). On the call was Trevena's President and Chief Executive Officer Carrie Bourdow … [Read more...] about Trevena Inc: A Budding Innovator Rooted In A Nobel Prize Winning Discovery
Biopharma Stock Watch July 22nd-26th, 2019
Source: MS Money Moves Week over week we see a slight improvement in the performance of the healthcare sector (represented as the XLV) and biotech industry (represented as the XBI) compared to the … [Read more...] about Biopharma Stock Watch July 22nd-26th, 2019
Biopharma Stock Watch July 15th-19th
Source: MS Money Moves July 8th-12th the Healthcare sector underperformed the greater markets as evident by the XLV and the IBB closing down -.66% and -2.06%, respectfully. The XBI stayed … [Read more...] about Biopharma Stock Watch July 15th-19th
Biopharma Stock Watch July 8th-12
Source: MS Money Moves Overall it was a red week for biotech whereas the greater market (S&P, NASDAQ, and DOW) gained a little under +1% each. In the past 30-days the healthcare sector … [Read more...] about Biopharma Stock Watch July 8th-12
Krystal Biotech (NASDAQ: KRYS) is On Track to Bring the First “Off the Shelf” Gene Therapy to Market
While writing my weekly Biopharma Stock Watch article for our members, I stumbled across an exciting clinical-stage gene therapy company Krystal Biotech (Nasdaq: KRYS). Since we started following KRYS … [Read more...] about Krystal Biotech (NASDAQ: KRYS) is On Track to Bring the First “Off the Shelf” Gene Therapy to Market
Biopharma Stock Watch July 1st-4th
It suffices to say Q2 2019 (April-June) has been a wild ride. In 1Q19 the market bounced back with a vengeance from its low-point in December 2018 when it appeared the U.S and China were on the cusp … [Read more...] about Biopharma Stock Watch July 1st-4th
Evolus: A Performance Beauty Company “Built to Grow Overnight”: Part 2
To recap, in part 1 we talked about Evolus (Nasdaq: EOLS), a relatively young company (no pun intended) entering the medical aesthetics market. Their first product Jeuveau was approved by FDA in … [Read more...] about Evolus: A Performance Beauty Company “Built to Grow Overnight”: Part 2
Evolus: A Performance Beauty Company”Built to Grow Overnight”: Part 1
Sometimes the best buying opportunities are when a company is between post-FDA approval and when sales roll in. Usually this is not the case as it takes time for sales to ramp up. Its risky for sure; … [Read more...] about Evolus: A Performance Beauty Company”Built to Grow Overnight”: Part 1